FIBTEM identifies functional fibrin abnormalities associated with an increased risk of traumatic intracranial bleed progression, in those where conventional testing is normal.

https://journals.lww.com/jtrauma/abstract/2026/01000/low_fibtem_amplitude_in_neurotrauma__true_plasma.20.aspx

Your work in anticoagulation and antithrombotic care matters — and you don’t have to do it alone.

Join AC Forum for a global community, clinical tools, trusted education & CE, recognition, and a focus on safer care. Supports all experience levels.

👉 Join for free: acforum.org/online/pages...

If you missed our webinar on DOAC-Sensitive Testing, the full recording is now available on AC University. It covers lessons from decades of warfarin testing, use of anti-Xa assays, & future DOAC technologies.

Watch it: acforum.org/web/educatio...

Explore more webinars & resources on AC University

👉 Have you registered yet?

Join us on Thur, Jan.8, at 12pm ET for an upcoming webinar, DOAC-Sensitive Testing: Emerging Evidence, Practical Applications, and What’s Next, to learn how it can support safer, more precise antithrombotic care.

🎓 Free to attend — submit your questions: bit.ly/4qepZTK

🔥The 25 Hottest Articles of 2025🔥

The tissue-plasminogen activator–challenged thromboelastography provides a comprehensive assessment of fibrinolysis in the severely injured

#JoTACS #MedSky

https://journals.lww.com/jtrauma/abstract/2025/04000/the_tissue_plasminogen_activator_challenged.8.aspx

💡 How can DOAC-sensitive testing support safer, more precise anticoagulation care?
Join us on Thursday, January 8 at 12:00 pm ET for an upcoming webinar,
DOAC-Sensitive Testing: Emerging Evidence, Practical Applications, and What’s Next.

🎓 Free to attend — submit your questions:
👉 bit.ly/4qepZTK

After mechanical thrombectomy for acute LVO stroke, intra-arterial alteplase increased the rate of excellent 90-day functional outcomes without raising symptomatic intracranial hemorrhage.

ja.ma/49ZufBG